Impact of Vendor Systems on Ambulatory Medication Safety

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00773500

Acronym

BWHCERT5E

Enrollment

Registered

2008-10-16

Start date

2008-09-30

Completion date

2011-10-31

Last updated

2012-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Errors

Keywords

Medication Errors

Brief summary

Our objective is to determine the effects of electronic prescribing on medication safety including medication errors, near misses and preventable adverse drug events in the ambulatory setting. Study design will be a longitudinal evaluation of errors early after implementation and after sustained use.

Detailed description

We will compare the effects of different vendor-based electronic prescribing systems on ambulatory medication safety in various settings, including rural and underserved areas and determine the effects of electronic prescribing systems on ambulatory medication safety over time.

Interventions

OTHERElectronic prescribing

Implementation of a commercially available electronic prescribing system with clinical decision support

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* \>=0.75 FTE providers

Exclusion criteria

* \<0.75 FTE providers

Design outcomes

Primary

Measure	Time frame
prescribing error	1 year

Secondary

Measure	Time frame
near misses	1 year
preventable adverse drug events	1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026